Disseminated intravascular coagulation;Coagulación intravascular diseminada

Medicina Clinica

Volumn 127, Issue 20, 2006, Pages 785-789

  Páramo, José A ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING INHIBITOR; FIBRINOGEN; HEPARIN;

ARTICLE; CONGENITAL BLOOD VESSEL MALFORMATION; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; HELLP SYNDROME; HEMOSTASIS; HUMAN; IMMUNOPATHOLOGY; INFECTION; INJURY; LABORATORY DIAGNOSIS; LIVER DISEASE; NEOPLASM; PATHOPHYSIOLOGY; PREGNANCY OUTCOME; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 33846339472     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13095816     Document Type: Article

References (32)

1. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med. 1999;341:586-92.
2. Mann KG. Thrombin formation. Chest. 2003;124:43-10S.
3. Mackman N. Role of tissue factor in hemostasis, thrombosis and vascular development. Arterioscler Thromb Vasc Biol. 2004;24:1015-22.
4. Esmon CT. New mechanisms for vascular control of inflammation mediated by natural anticoagulant proteins. J Exp Med. 2002;196:561-4.
5. Carr JM, McKinney M, McDonagh J. Diagnosis of disseminated intravascular coagulation. Role of D-dimer. Am J Clin Pathol. 1989;91:280-7.
6. Páramo JA, Pérez JL, Serrano M, Rocha E. Types 1 and 2 plasminogen activator inhibitor and tumor necrosis factor alpha in patients with sepsis. Thromb Haemost. 1990;64:3-6.
7. Mant MJ, King EG. Severe, acute disseminated intravascular coagulation: A reappraisal of its pathophysiology, clinical significance and therapy based on 47 patients. Am J Med. 1979;67:557-63.
8. Rocha E, Páramo JA, Montes R, Panizo C. Acute generalized widespread bleeding: diagnosis and management. Haematologica. 1998;83:1024-37.
9. Van der Poll T, De Jonge E, Levi M. Regulatory role of cytokines in disseminated intravascular coagulation. Sem Thromb Hemost. 2001;27:639-65.
10. Zerleder S, Hack CE, Wuillemin WA. Disseminated intravascular coagulation in sepsis. Chest. 2005;128:2864-75.
11. Dellinger RP. Inflamation and coagulation: implications for the septic patient. Clin Infect Dis. 2003;36:1259-65.
12. Selladurai BM, Vickneswaran M, Duraisamy S, Atan M. Coagulopathy in acute head injury. A study of its role as a prognostic indicator. Br J Neurosurg. 1997;11:398-404.
13. Sack GH, Levin J, Bell WR. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasmas: clinical pathophysiologic and therapeutic features. Medicine (Baltimore). 1977;56:1-37.
14. Velasco F, López-Pedrera R, Páramo JA. Patogénesis y tratamiento de la alteración hemostática en la leucemia aguda promielocítica. Med Clin (Barc). 1996;107:59-61.
15. Weiner CP. The obstetric patient and disseminated intravascular coagulation. Clin Perinatol. 1986;13:705-17.
16. Vincent JL, De Backer D. Does disseminated intravascular coagulation lead to multiple organ failure? Crit Care Clin. 2005;21:469-73.
17. Toh CH. Laboratory testing in disseminated intravascular coagulation. Sem Thromb Hemost. 2001;27:653-5.
18. Levi M, De Jonge E, Meijers J. The diagnosis of disseminated intravascular coagulation. Blood Rev. 2002;16:217-23.
19. Taylor FB, Toh CH, Hoots WK, Wada H, Levi M, on behalf of the Scientific Subcommitteee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327-30.
20. Ten Cate H. Thrombocytopenia: one of the markers of disseminated intravascular coagulation. Pathophysiol Haemost Thromb. 2003;33:413-6.
21. Cauchie P, Cauchie C, Boudjeltia KZ, Carlier E, Govaerts D, Migaud-Fressart M, et al. Diagnosis and prognosis of overt intravascular coagulation in a general hospital. Meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation. Am J Hematol. 2006;81:414-9.
22. Levi M. Dissminated intravascular coagulation. What's new? Crit Care Clin. 2005;21:449-67.
23. George JN. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006;354:1927-35.
24. Páramo JA, Rocha E. Hemostasis in advanced liver disease. Sem Thromb Hemost. 1993;19:184-90.
25. Egerman RS, Síbai BM. Imitators of preeclampsia and eclampsia. Clin Obstet Gynecol. 1999;42:551-62.
26. Levi M, De Jonge E, Van der Poll T. Plasma and plasma components in the management of disseminated intravascular coagulation. Best Pract Res Clin Haematol. 2006;19:143-55.
27. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainant JF, López-Rodríguez A, et al, for the Recombinant Human Activated Protein C World Wide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety or recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
28. Dellinger RP. Recombinant activated protein C: decisions for administration. Crit Care Med. 2005;24:75-81.
29. Jonge E, Van der Poll T, Kesecioglu J, Levi M. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience. Sem Thromb Hemost. 2001;27:667-74.
30. Abraham E, Laterre PF, Garg R, Levy H, Talwar D, Trzaskoma BL, et al, for the Administration of Drotrecogin Alfa (activated) in Early Stage Severe Sepsis (ADDRESS) Study Group. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med. 2005;353:1332-41.
31. Kienast J, Juers M, Wiederman CJ, Hoffman JN, Osterman H, Strauss R, et al. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost. 2006;4:90-7.
32. Bick RL. Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management guidelines for care. Clin Appl Thromb Hemost. 2002;8:1-31.